B. Braun Medical Inc. recalled 47,148 containers of Sodium Chloride Injection on August 18, 2025. The recall follows the discovery of particulate matter in the product. Consumers and healthcare providers must stop using the injection immediately.
Presence of Particulate Matter.
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Letter
The recall affects 0.9% Sodium Chloride Injection USP in 1000 mL containers, labeled with Lot #: V3K770 and an expiration date of January 31, 2026. The product is available by prescription only and was distributed nationwide in the U.S.
The presence of particulate matter in the Sodium Chloride Injection poses a significant health risk. Particulates can lead to serious complications when injected.
No specific injury or incident counts have been reported associated with this recall. However, the potential for serious adverse effects exists.
Stop using the recalled Sodium Chloride Injection immediately. Consumers should contact B. Braun Medical or their healthcare provider for further guidance.
For more information, contact B. Braun Medical Inc. at the number provided in the recall notification letter.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.